Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-02-08 @ 9:15 PM
Study NCT ID:
NCT03937869
Status:
COMPLETED
Last Update Posted:
2020-12-19
First Post:
2019-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
Sponsor:
Lupin Research Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-22
First Submit QC Date:
None
Study First Post Date:
2019-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL